Pakistan Lawmakers Raise Alarm Over Counterfeit Medicines and Vaccines in Rural Areas

Pakistani lawmakers have expressed serious concern over the reported circulation of counterfeit medicines and vaccines in rural communities, warning that weak regulatory oversight could endanger public health.

The issue was discussed during a meeting of the Senate Functional Committee on Problems of Less Developed Areas, where members questioned the effectiveness of pharmaceutical monitoring and regulatory enforcement.

The committee raised concerns about weaknesses in oversight by the Drug Regulatory Authority of Pakistan (DRAP), particularly in areas where access to quality healthcare remains limited.

Lawmakers also discussed the continued presence of polio in Pakistan and Afghanistan, highlighting the importance of strengthening vaccination programmes and ensuring the reliability of medical supplies.

Federal and provincial health authorities were directed to address the concerns and provide information about regulatory gaps within 10 days.

Officials informed the committee that a new two-dimensional barcode tracking system for pharmaceutical products became effective on October 10, 2026.

The system is designed to help consumers verify medicine authenticity using mobile phones, potentially improving transparency and reducing the circulation of counterfeit products.

Officials also revealed that a National Vaccine Policy was awaiting federal cabinet approval.

The discussion highlights the need for stronger monitoring, reliable medicine distribution and improved public awareness.

Healthcare experts generally recommend purchasing medicines from licensed pharmacies and seeking professional advice when concerns arise about a product’s authenticity.

Strengthening pharmaceutical regulations will remain essential to protecting vulnerable communities and restoring confidence in Pakistan’s healthcare supply chain.